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THE ROLE OF TRANSMEMBRANE IMMUNOGLOBULIN DOMAIN 
CONTAINING-1 (TMIGD1) IN RENAL EPITHELIAL CELLS 
JOSEPH YEGHISHE TASHJIAN 
ABSTRACT 
 Kidney disease has a high incidence across the globe and can be caused by acute 
and chronic injury. Current methods of treatment range from prevention and management 
with diet and extend to hemodialysis at End Stage Renal Disease (ESRD). 
Transmembrane Immunoglobulin Domain Containing-1 (TMIGD1) is mainly expressed 
in kidney and the intestines and is involved in cell-cell interaction of epithelial cells. This 
thesis investigated the potential role of TMIGD1 in the development of chronic kidney 
disease and tubular epithelial cell injury in CRISPR/Cas9-TMIGD1 transgenic mouse. 
Treatment of wild-type mice with adenine showed that TMIGD1 is downregulated in 
response to adenine-induced renal cell injury.  CRISPR/Cas9-TMIGD1 -/+ mice treated 
with adenine displayed significantly increased tubular damage compared to wild-type 
mice. Additionally, expression of TMIGD1 was directly correlated with localization of 
C/EBPβ to nucleus, a transcription factor that is known to regulate expression of 
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Approximately 30 million people are diagnosed with some form of renal injury or 
kidney disease in the United States (CDC, 2017). Renal Injury can rapidly manifest from 
occlusion that would cause ischemic tubular damage, or due to nephrotoxic agents 
initiating chronic kidney disease to advance over time (Markis and Spanou, 2016). 
Proximal tubule injury is a key diagnostic marker of acute kidney injury (AKI) (Kaissling 
et al., 2013) and has been identified as the dominant trigger for progression to chronic 
kidney disease (CKD) (Takaori et al., 2016). Tubules compose approximately 95% of the 
nephron and stress is likely to lead to tubulointerstitial fibrosis (Kaissling et al, 2013; 
Takori et al., 2016; Nath, 1992; Markis and Spanou, 2016). Development and progression 
of end stage kidney disease may be accelerated by co-morbidities such as diabetes and 
cardiovascular disease (Prichard, 2000). Renal tubular epithelial cells plasticity and 
resilience is vital for the response to everyday injury and maintenance of serum filtration 
(Smith et al., 2006; Chevalier, 2017). 
 
Renal function: 
Daily, the renal tubule reabsorbs approximately 99% of water and 25,000 mmol 
of sodium (Taal et al., 2011, Lyu et al., 2018). As blood is transported from the renal 
artery to the renal vein in the Malpighian body where pressure reduces and enters the 
glomerulus. Plasma is transported into the lumen water, sodium, potassium, and chloride 
ions, are exchanged as it advances from the proximal convoluted tubule, the loop of 
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Henle, and through the distal convoluted tubules to produce urine in the collecting duct 
(Mullins et al., 2016; Taal et al., 2011). The filtration process is regulated by osmosis, 
active and passive transport, and blood pressure to return purified plasma to the renal 
vein and exit the kidney (Marieb and Hoehn, 2013). This region of the kidney is 
identified as the nephron, where cells have evolutionarily specialized for efficient 
filtration and allow for reabsorption of ions (Chevalier, 2017). The nephron is segmented 
into the convoluted proximal and distal tubules and the loop of Henle that function to 
remove toxins from blood and is exposed to endogenous and exogenous solutes through 
this process (Smith et al., 2006). 
In response to pressure and concentration of nutrients, such as sodium, the kidney 
has evolutionarily developed a process of reabsorption to maintain homeostasis and 
regulate the excretory processes (Chevalier, 2017). Aldosterone is secreted from the 
adrenal cortex to regulate the sodium retention and the increases water recovery process 
stimulated by angionestin II (OpenStax, 2016). These molecules are expected to induce 
the progression of renal fibrosis and regulate function.  
Pluripotent stem cells distributed throughout the kidney differentiate and may 
actively repair renal injury in early development regulated by markers of injury and 
toxicity of endogenous and exogenous solutes (Little and McMahon, 2012; Marcheque et 
al., 2019). In a mature kidney, responses to injury not regulated by pluripotent stem cells 
but dedifferentiated epithelial cells in the proximal region of the nephron that undergo 




Renal structure:  
The nephron is where a majority of waste is removed from the blood, and 
nutrients are metabolized (Marieb and Hoehn, 2013). Blood enters the Malpighian body 
where the pressure reduces in the glomerulus and protein is absorbed. The remaining 
fluid passes through the Bowman capsule and into the renal tubules. Each tubule is 
segmented into three parts. The Loop of Henley absorbs potassium, chlorine, and sodium 
into the blood (Marieb and Hoehn, 2013; Taal et al., 2011). 
 A defining feature of the renal tubule and collecting duct is the simple cuboidal 
structure consisting of polar epithelial cells on a basement membrane to better aid in 
filtration (Marieb and Hoehn, 2013). 
 
Renal tubular and proximal epithelial cells: 
Renal tubular epithelial cells are organized based on their location, either 
proximal or distal. The proximal tubule is the segment of the nephron from the renal pole 
of the Bowman’s Capsule to the beginning of the loop Henley (Marieb and Hoehn, 2013). 
The distal convoluted tubule has the highest concentration of ion transport in the nephron 
regulates by dietary salt, angionestin II, and aldosterone (McCormick and Ellison, 2015). 
The product of tubular filtration results in urine collected in the bladder and are prepared 
for excretion. These cells differ from the proximal convoluted tubule as they almost 
entirely lack microvilli and are named based on their proximity to the renal cortex 
(Marieb and Hoehn, 2013).  
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The renal proximal convoluted tubules constitute for over 50% of the volume in a 
healthy kidney, for which the change in mass and size is attributed to its development 
from gestation to childhood (Chevalier and Charlton, 2014) The proximal tubule allows 
active or passive transport of water, sodium and oxygen reabsorption to conserve energy 
and aid in the transport of ions (Kiil et al., 1961). Due to the primary cell type in the 
organ, the logical progression would lead us to analyze the proximal tubules in the 
diseased state (Taal et al., 2011). Interestingly, in acute kidney injury (AKI) the nephrons 
undergo hypertrophy while in the aged state or in chronic kidney disease (CKD) the 
proximal tubules experience atrophy (Chevalier, 2017). The proximal kidney epithelial 
tissue is exposed to more superficial damage and response to injury via hypertrophy as 
adult kidneys are not able to regenerate (Little and McMahon, 2012). Brush border 
increases surface area and the capacity of filtration and secretion through the membrane 
(Marieb and Hoehn, 2013). 
 
Clinical relevance of renal injury: 
Chronic kidney disease (CKD) or disorders related to the processing of blood 
occurs in more than 15% of adults in the United States (CDC, 2017). According to the 
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), the main 
causes of CKD are due to high blood pressure and diabetes. High blood pressure effects 
the proximal renal tubules which can lead to the thinning of the endothelial wall and 
(Chavelier, 2016). Clinical measures such as Blood Urea Nitrogen (BUN) and Creatinine 
are commonly used to determine the success of filtration and excretion (Markis and 
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Spanou, 2016; Takaori et al., 2016; Paueksakon and Fogo, 2014; Weber et al., 2017). 
Renal damage can be indicated by increases in these markers. BUN is used to measure 
the amount of nitrogen present in blood as a known byproduct of urea, in the event these 
markers are higher, it would indicate renal damage. Another byproduct of a waste 
product is creatinine, for which if in serum, could indicate renal damage (Weber et al., 
2017). 
Uremic solutes are also used to measure clinical progression of CKD. Certain 
uremic solutes are bound to serum albumin, such as indoxyl sulfate, indoxyl acetate and 
kynurenine, and are considered to enhance vascular damage and endothelial dysfunction 
in end stage renal disease at increased concentrations (Moshe et al., 2015; Pletinck et al., 
2013; Duranton et al., 2012). Indoxyl sulfate (IS) and Indoxyl acetate (IA) levels are 
commonly associated with cardiovascular diseases and elevate oxidative stress (Lin et al., 
2012; Gajjala et al., 2015; Moshe et al., 2015). Kynurenine is a cytotoxic compound of 
tryptophan and is connected to chronic renal failure and metabolic disruption 
(Tankiewicz et al., 2003).  
 
Pathophysiology of tubulointerstitial fibrosis: 
Oxidative stress-associated renal injury can lead to tubulointerstitial fibrosis and 
reduce the capacity for renal function (Chen et al., 2014). Proximal tubules have the 
ability to intrinsically initiate a cascade of pro-inflammatory cytokines and chemokines to 
induce the formation of fibroblasts (Iwano et al., 2002; Zeisberg and Neilson, 2010). 
Clinically relevant biomarkers of nephrotoxicity include but are not limited to 
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Transforming growth factor beta-1, Reactive Oxygen Species (ROS), Kidney Injury 
Marker-1 (KIM-1), Neutrophil gelatinase-associated lipocalin (NGAL), and Interleukin-
18. Novel biomarkers of renal tubular injury in acute and chronic injury are IL-18, KIM-
1, and NGAL (Han et al., 2002; Devarajan, 2008; Weber et al., 2017). ROS and TGF-b1 
are used as biomarkers of metabolic changes associated with alteration of proximal tubule 
phenotype (Zhao et al., 2016). After a series of insults related to the change in glomerular 
filtration and the release of inflammatory mediators, the stimulation of cell proliferation 
and fibrosis occurs resulting in accumulation of extracellular matrix (ECM) molecules 
(Gajjala et al., 2015). Additionally, histological analysis indicating epithelial-
mesenchymal transition (EMT) and inflammation are hypothesized to be concomitant 
with the progression of tubulointerstitial fibrosis (Chen et al., 2014).  
Over the years, various mouse models such as adenine diet were developed to 
study CKD. In this model, mice were exposed to adenine diet to induce inflammation, 
tubulointerstitial nephritis, and anemia (Jia et al., 2013; Ali et al., 2013; Rahman et al., 
2018). This damage associated with this model is not localized to the epithelial tissue, but 
also replicates vascular calcification and hemodynamic increase were significantly 
reported (Shobeiri et al., 2013).  
 
Role of TMIGD1 in renal proximal tubules 
Transmembrane Immunoglobulin Domain-Containing 1 (TMIGD1) is a protein 
that is comprised of two extracellular immunoglobulin (Ig) domains and an intracellular 
region and is a member of the IGPR-1 family of cell adhesion molecules (Arafa et al., 
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2015; and Wang et al., 2016). Specifically, the murine and human sequence homology is 
greater than 90% and when compared to IGPR-1, also known as TMIGD2, there is 31% 
homology (Arafa et al., 2015). One difference between TMIGD1 and IGPR-1 is a shorter 
intracellular region that lacks a proline rich region (Arafa et al., 2015).  Similar to the 
IGPR-1 family of proteins, TMIGD1 mediates adhesion via homophilic trans-
dimerization of the extracellular region (Meyer et al., 2018; and Arafa et al., 2015). 
TMIGD1 is highly conserved protein and expressed in the kidney, small intestines and 
colon of humans (Uniprot). The apparent molecular weight of TMIGD1 is 29kda and 
45kda, which corresponds to un-glycosylated and glycosylated TMIGD1, respectively 
(Arafa et al., 2015).  
 
 
Figure 1. Structure of TMIGD1 and IGPR-1. Pictured is a rendering of the IGPR-1 




Expression of TMIGD1 in renal cell carcinoma (RCC) is suggested to be a novel 
tumor suppressor, which is regulated by CCAAT/enhancer-binding protein-β (C/EBP-β) 
(Meyer et al., 2018). CEBP-β regulation of TMIGD1 transcription was characterized 
using electrophoretic mobility shift assay (EMSA) (Meyer et al., 2018). Once the protein 
transports to the cell surface it homodimerizes and contributes to the permeability of 
epithelial cells as shown using immortalized kidney cell lines, HEK293 and HK2 (Arafa 
et al., 2015; Wang et al., 2016). We hypothesize that this property of cell- cell adhesion 
may contribute to the plasticity and response of renal epithelial cells in animal and 
disease models.  
Recent studies suggest the presence of TMIGD1 promotes survival of kidney 
epithelial cells from oxidative cell injury (Arafa et al., 2015) as well as a loss or down 
regulation in certain cancers such as colorectal cancer and the diseased state of the 
intestines, such as colitis (Roberts et al., 2015, and Lee et al., 2015). Model organisms 
such as rats, mice, zebrafish have shown mRNA and protein expression differences in 
diseased states analyzed via gene ontology to be sex dependent and potential DNA 
marker of fertility (Lickwar et al., 2017; Vettorazzi et al., 2019; Huang et al., 2018). 
When comparing model organisms and animal models homologous for human disease, 
data suggests high similarity in the ileum of two model organisms, the mouse and 
zebrafish (Lickwar et al., 2017). Research studies suggest TMIGD1 expression regulates 
proximal kidney epithelium permeability which may induce phenotypic changes induced 




Specific Aims:  
The purpose of this study was to investigate the role of TMIGD1 as a potential reno-
protective protein in normal and pathophysiological conditions of CKD.  
Specific aims of this study were: 
1. Investigate the phenotypic differences with the loss of TMIGD1 expression in cell 
culture and transgenic mouse generated by CRISPR/Cas9. 
2. Analyze the effect of TMIGD1 loss in the adenine induced chronic kidney disease 




Adenine Animal Model 
 All animal models used were reviewed and approved by the Ethical Committee of 
Boston University School of Medicine (BUSM, Boston, MA). All procedures were 
performed in accordance with the relevant guidelines and regulations. Transgenic 
TMIGD1 mice were produced using CRISPR/Cas9 technology (Boston University 
Medical Campus).   
Chronic kidney disease (CKD) was induced in 8-10-week-old mice using the 
adenine induced dietary model of CKD.  In one experiment, mice were administered a 
diet supplemented with 0.25% adenine (Research diets).  Mice were sacrificed at day 1, 
4, and 14 of the start of the 0.2% adenine diet.  
Later, using Wild type and TMIGD1+/-, 0.2% adenine was administered for 32 
days and end-stage kidney disease was induced. Over the course of the month, plasma 
was collected at 2 weeks and 4 weeks post exposure. After 4 weeks exposure, animals 
were sacrificed. Tissue was harvested and either formalin fixed, and paraffin imbedded.  
 
Tissue processing and sectioning: 
 Tissue harvested from mice were flash frozen or fixed in 10% formalin overnight 
at 4 degrees Celsius. Once Formalin fixed, the tissue was placed in a cassette and 
submitted to the Experimental Pathology Laboratory Service Core (EX+). Tissue was 
dehydrated and saturated in paraffin. Processed tissue was then positioned, and paraffin 
embedded using the Embedding machine on the fourth floor of 670 Albany St in the 
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Department of Pathology. Using a microtome, paraffin embedded tissue was sectioned to 
the thickness of 4µm. Tissue sections were transferred into a water bath regulated at 37 
degrees Celsius and mounted on positively charged glass slides. Slides were then baked 
for 1 hour in a 60-degree Fahrenheit incubator prior to staining.    
 
Cell Culture:  
Human Kidney Renal Proximal Tubules (HK2), kindly provided by Dr. Vipul 
Chitalia (Boston University) were grown in Dulbecco’ s Modified Eagle’ s Medium 
(DMEM), supplemented with 10% fetal bovine serum and penicillin/streptomycin. 
 
Immunocytochemistry: 
In preparation of staining, human renal proximal tubular epithelial cells (HK2) 
were grown to 70% confluence in an incubator regulated at 37 degrees Celsius. Glass 
coverslips were sterilized using 70% Ethanol in the chemical fume hood.  The sterilized 
coverslips were placed in a new petri dish where cells were inoculated with fresh media 
and allowed to adhere for 24 hours at 37 degrees Celsius. Once the desired confluence 
was achieved the coverslips were washed with 1X PBS by swirling the petri dish. The 
PBS was decanted and fixed in 4% Paraformaldehyde at room temperature for 10 
minutes. Coverslips were subsequently washed three times with 1x PBS, followed by 
permeabilization using 0.3% Triton X-100 in 1xPBS solution for 10 minutes. Coverslips 
were washed 3 times with 1x PBS. 5% Bovine Serum Albumin was added to each slide 
for 1 hour to block non-specific proteins. The blocking solution was aspirated, and 
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primary antibody was added. Coverslips were stored in a humidified chamber overnight 
at 4 degrees Celsius. Each coverslip was washed three time with 1X PBS. The fluorescent 
tagged secondary antibody was added at X concentration in the dark for 1 hour at room 
temperature. Cover slips were washed three times with 1X PBS. Coverslips were 
mounted with VectaMount with DAPI. Slides were imaged using a confocal microscope 
in the Cellular Imaging Core.  
 
Immunofluorescence:  
To prepare paraffin embedded slides for staining, tissue is baked at 65 degrees 
Fahrenheit for 30 minutes to 1 hour. Tissue is gradually hydrated in a series of decreasing 
ethanol solutions beginning with Xylene to 70% ethanol and finally water.  Antigen 
retrieval was performed using a 10mM Sodium Citrate and 0.05% Tween solution (pH 
6.0) and maintained at 95 degrees Fahrenheit for two ten-minute intervals using the EZ 
Retriever System V.2. Slides were rotated between heating. Slides were submerged in the 
citrate solution for 45 minutes to cool to room temperature. Slides were washed in 1xPBS 
for 10 minutes. A hydrophobic barrier was drawn around the tissue. Tissue was 
permeabilized using 0.3% Triton X-100 in 1xPBS for 10 minutes. Tissue was washed 3 
times with 1xPBS for 2 minutes. 5% Bovine Serum Albumin and 0.3% Triton X-100 was 
used to block for 1 hour. Primary antibody was mixed with the blocking buffer at 4 
degrees Fahrenheit overnight in a humidified chamber. Slides were washed with 1xPBS 3 
times. Secondary fluorescent antibody was mixed with the blocking buffer and applied to 
tissue in the dark for 30 to 45 minutes. Slides were washed with 1xPBS 3 times. 
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VectaMount infused with DAPI to stain nuclei and mounted using a coverslip. Slides 
were dried and sealed with nail polish. Stained slides are stored long-term in a dark 
container at 4 degrees Celsius. Slides were imaged using a confocal microscope in the 
Cellular Imaging Core.  
 
Immunohistochemistry: 
Immunohistochemistry staining was performed as per the manufacturer's 
instruction with the use of the EXPOSE rabbit-specific horseradish 
peroxidase/diaminobenzidine detection immunohistochemical kit (Abcam, Cambridge, 
MA). First the slide was hydrated gradually using the following procedures 2x 5 minutes 
in Xylene, 2x 3 minutes in 100% Ethanol, 2x 2 minutes 95% Ethanol, 2x 2 minutes in 
70% Ethanol, then stored in deionized water for transport. Antigen retrieval was achieved 
by submerging the slide in 10mM Sodium Citrate and 0.05% Tween solution (pH 6.0) 
and heated to 95 degrees Fahrenheit for two ten-minute intervals using the EZ Retriever 
System V.2. In between the intervals the slide was rotated. The Slide remained 
submerged in the heated Sodium citrate solution for 45 minutes to come to room 
temperature. Once at room temperature the slide was washed in 0.05% TBS Tween (1L 
1xTBS + 0.5mL Tween 20) for 10 minutes. A hydrophobic barrier was drawn around the 
tissue. The slide was transferred to a humidified chamber and remained hydrated with 
enough room temperature hydrogen peroxide from the ab80436 kit. This incubated for 10 
minutes. Slides were washed twice in 0.05% TBS Tween for 5 minutes. 
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Sections were blocked using serum free blocking buffer for 30 minutes at room 
temperature (Abcam ab80436).  Anti-rabbit TMIGD1 primary antibody was diluted in 
blocking buffer (1:500) and incubated at 4 degrees C overnight. The following day the 
slide was returned to room temperature and washed in 0.05% TBS Tween for 5 minutes, 
twice. The secondary antibody specific to anti-rabbit primaries from ab80436 was added 
for 30 minutes in the dark. The slide was then washed two times in 0.05% TBS Tween 
for 5 minutes each. Using the DAB Substrate and DAB Chromogen to create a solution 
with the following concentrations 1.5mL:1 drop, respectively. This solution was then 
added to the tissue for 30 seconds. The reaction was stopped in deionized water. To 
counter stain, the slides were submerged in a 1:10 dilution hematoxylin solution and let 
sit for 45 seconds. The slides were rinsed with deionized water and dehydrated using the 
following procedure, 2x 2 minutes 70% Ethanol, 2x 95% Ethanol, 2x, 3-minute 100% 
Ethanol, and finally 2x 5 minutes Xylene. Slides were let air dry and mounted using 
VectaMount.  
 
Picrosirius Red Staining: 
 Using Picrosirius Red Stain Kit (Abcam, cat #ab150681) collagen type I and II 
fibers and muscle tissues were stained to identify potential differences in fibrosis in 0.2% 
Adenine treated Wildtype and TMIGD1 +/- mice. Paraffin embedded tissue sections were 
deparaffinized and hydrated. Tissue sections were incubated with Picrosirius red stain for 
60min at room temperature. Sections were rinsed in two changes of Acetic Acid and then 
once with molecular grade absolute ethanol. The tissue was then dehydrated in two 
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changes of absolute alcohol for 3 minutes. Slides were cleared in xylene and allowed to 
dry in the laminar flow hood. Tissue sections were mounted using VectaMount instant 
seal. Images were obtained using the light microscope (Olympus BX60 with Q Imaging 
Retiga 2000R camera with Q Capture software) in the Cellular Imaging Core.  
 
Trichrome stain: 
Mounted tissue sections were stained for identification of fibrosis using (Abcam, 
cat #ab150686).  Slides were deparaffinized and hydrated and then placed in preheated 
Bouin’s Fluid for 1 hour. After a rinse in water, tissue was incubated in Weigert’s Iron 
Hematoxylin for 5 minutes. Tissue was rinsed. Next, the tissue was submerged in 
Biebrich Scarlet/Scid Fuchion solution for 15 minutes. Tissue was rinsed. Then placed in 
phosphomolybdic and phosphotungstic acid solution for 15 minutes and directly placed 
into Aniline Blue for 7 minutes. Tissue was rinsed in water and incubated in acetic acid 
for 3 minutes. Tissue was dehydrated and mounted.  
 
Periodic Acid Schiff (PAS):  
 Mounted tissue sections were submitted to Boston University Experimental 
Pathology Laboratory Service Core (EX+) for special staining. This stain was used for 






Hematoxylin & Eosin Stain (H&E):  
Mounted tissue sections were submitted to Boston University Experimental 
Pathology Laboratory Service Core (EX+) for special staining. General physiology was 
examined using this technique.  
 
Western Blot Analysis:  
 Harvested tissue was flash frozen in either liquid nitrogen or dry ice and stored at 
-80 degrees Fahrenheit until lysis. Frozen tissue was homogenized and sonicated in 
Sodium orthovanadate buffer. BCA assay was used to determine the protein 
concentration. 5X Sample Buffer (3.8% Tris-base, 50% glycerol, 5% sodium dodecyl 
sulfate (SDS), 5% β-mercaptoethanol, 0.0025% bromophenol blue) was added to lysates 
before being placed on heat block set to 95℃ for no longer than 5 minutes. Lysate was 
pipetted on 2% agarose gel. Membranes were blocked with blotto (2% non-fat dry milk 
and 0.05% Tween-20 in Western Rinse) for 1 hour on a rocker. Membranes were then 
rinsed in a TBS and 0.05% Tween-100 (TBSt) solution three times for 5 minutes. 
Primary antibody was incubated for 1 hr at room temperature or overnight at 4 degrees 
Celsius. Following two 5 minutes washes in TBSt, membranes were incubated with 
secondary antibodies for 1 hour at room temperature. The membranes were washed again 






ImageJ Analysis:  
 Slides stained with Periodic Acid Schiff (PAS), Trichrome and Picrosirius Red 
were imaged using (Olympus BX60 with Q Imaging Retiga 2000R camera with Q 
Capture software). Six images of the renal cortex were captured per mouse and were 
blinded prior to analysis. Using FIJI software, the tif was uploaded and colors were 
separated using “Color Deconvolution” plug in and select PAS H. Three images were 
produced. Select image number 2 and edit with “Image” and “Adjust” the parameters to 
20 and 80. Be sure to set measurements to include percent area, then use the Analyze 
function to “Measure” the percent area. The percent area indicates the amount of 
glycogen and mucin positively stained. This process was completed for each image. All 
six images from each mouse was then averaged and plotted using GraphPad. The 
Trichrome stain was evaluated for the blue collagen the same way except the 
deconvolution was selected for the Mallory Trichrome. Using FIJI software, the tissue 
stained by Picrosirius red were evaluated by the amount of Red using the technique 
explained ImageJ to split the image to RGB stack, threshold the ‘Green’ image, and 
measure the percent area positive stain.   
  









Figure 2. Wild Type Expression of TMIGD1 and use of animal models of renal 
injury. Chronic kidney disease was induced using oral administration of adenine chow at 
the mousses’ device and sacrificed at day 0, 4 and 14 post exposure. Additionally, 
C/57BL6 mice (TMIGD1+/+) were exposed to the remnant kidney model (RKM) to 
induce progressive renal injury. TMIGD1 expression reduced over time. C/EBP-beta 
location over time has become less nuclear and more cytoplasmic.  
 
C/EBP-beta was previously identified as a transcription factor that regulates 
expression of TMIGD1 (Meyer et al., 2018). Using C57BL6 Wild-type kidneys 
demonstrated strong expression of the proteins in the untreated state was present at the 
nucleus. After exposure to 0.25% Adenine Chow, its expression at the nucleus was 
reduced, instead it was found in the cytoplasm of renal proximal tubules as early as 4 
days post exposure (Figure 2). To ensure this was not adenine or chronic kidney injury 
specific event, another set of wild-type mice were induced to a model of acute renal 
injury, the remnant kidney model (Jia et al., 2013; Kren and Hostetter, 1999). As shown 
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in Figure 2, as C/EBP-b expression in the kidney decreases, so does the overall 
expression of TMIGD1 in the proximal renal tubules.  
  
Figure 3. Expression of TMIGD1 and Nuclear Transcription factor. As the diseased 
state progresses, the renal expression of TMGID1 decreases and location changes in Wild 
type mice. 
 
In the renal proximal tubules, at higher magnification, of wildtype (TMIGD1+/+) 
mice, it was demonstrated that the amount of nuclear C/EBP-beta expression is shown to 
be relative to the amount of TMIGD1 expressed (Figure 3). The apical expression of 
TMIGD1 in wild type mice quickly diminishes as acute kidney disease progresses to 
chronic kidney disease at day 4 and then continues in day 14. Images representing the 
remnant kidney model are consistent with the end stage renal disease achieved by day 14 
exposure to 0.25% adenine (Figure 3). The immortalized cell line HK2, cells were 
cultured to confluence and exposed to endogenous uremic solutes for 24 hours and then 
fixed to be stained for C/EBP beta, the transcriptional regulator of TMIGD1. The nuclear 
counter stain of DAPI was used for location (Figure 4). 
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Figure 4. Immunocytochemistry of Human Renal Proximal Tubular Epithelial cells 
HK2 cells.  HK2 cells were cultured in media mixed with uremic solutes and stained for 
C/EBP-beta.  
 






























TMIGD1 loss effects renal health in Adenine-induced CKD  
Blood Urea Nitrogen (BUN) was measured from plasma after two weeks of 
exposure to 0.2% Adenine and then again after 4 weeks. At the 2-week mark, both groups 
of mice reported values of low to mid 70 mg/dL BUN which is consistent with significant 
renal damage (Figure 5A). By the fourth week of exposure however, the wild type mice 
showed a decrease in BUN suggesting repair from renal injury whereas the TMGID1+/- 
mice remained with severe renal injury. Due to the coagulation of collected serum, 
plasma was only able to be measured from three mice of each group. The comparison 
produced a significant difference using an unpaired students T test (p= 0.0473) (Figure 
5B). The adenine diet is expected to cause weight loss and in order to compare the mice, 
the average relative percent loss for each group was plotted. At termination, both groups 
began to gain weight without significant difference (Figure 5C). Another marker of renal 
injury measured was Creatinine, at week 4, plasma from four mice were assayed and did 
not produce statistical significance (p=0.0902) using a student’s T test. Data reported 
from the wild type mice showed a great deal of variability and due to the small sample 
size, results may change with further investigation (Figure 5D). The change in relative 
renal mass of TMIGD1+/- mice versus the TMIGD1+/+ reported a statistical difference 











Figure 5. Physiological difference in kidney in response to chronic injury with 
Mouse Model.  (A.) Blood Urea Nitrogen (BUN) at two weeks of adenine exposure 
showed similar stress between groups. (B.) BUN demonstrated a statistical significance at 
week 4 of 0.2% Adenine Chow but not 2 weeks exposure (p=0.04730). (C.) Average 
percent change in weights across time. (D.) Creatinine measurement at 4 weeks. (E.) 
Functional Renal mass (kidney weight/total weight) x100, suggesting hypertrophy in 
TMIGD1+/- mice.  
 
A two-way ANOVA with a Bonferroni correction was calculated to produce a p 
value of 0.0004 which demonstrated a significant difference between all genotypes of 
mice based on positive glycogen stain from Periodic Acid Schiff (PAS) staining between 
the untreated mice (Figure 6). Representative images at 20x magnification demonstrate 
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the difference in staining (Figure 6). When mice were exposed to 0.2% Adenine for 32 
days, TMIGD1+/- and TMIGD1+/+ kidneys were stained with PAS and compared again. 
Data reported produced a p value of 0.0430 (Figure 6). 
 
 
Figure 6. Morphological Image analysis of Untreated Kidneys (A.) PAS stain from 
TMIGD1 +/+, TMIGD1+/-, and TMIGD1 -/- Untreated at 20x magnification of the renal 
Amount of PAS stain in Untreated Kidney
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cortex. (B.) Demonstrates values calculated from images of untreated tissue using ImageJ 
(C.) Demonstrates values calculated from images of tissue exposed to 0.2% adenine for 
32 days using ImageJ. (D.) PAS stain from 0.2% adenine treated TMIGD1 +/+ and 
TMIGD1 +/- at 20x magnification of the renal cortex. 
 
 
Figure 7. Proximal Tubule Dilation and Necrosis. Of the PAS images captured, 
the number of dilated and necrotic proximal tubules were counted, and an average was 
produced. (A.) There was a significant difference between the TMIGD1 +/+ and 
TMIGD1 +/- exposed to 0.2% Ad for 32 days (p=0.0213). (B) There was no difference in 
the number of proximal tubules with necrotic debris (p=0.15828). 
 
The number of dilated proximal tubules and proximal tubules with necrotic debris 
were counted from the quantified images stained for PAS in Figure 6 and presented in 
Figure 7. There are significantly more dilated proximal tubules captured in the 20x field 
of the TMIGD1 +/- mice than that of the TMIGD1 +/+ mice (Figure 7).  Images were 
captured of the renal cortex of adenine treated mice stained for picrosirius red, a marker 
of Type II and III collagen. When compared, the averages of the wildtype mice and the 
heterozygous mice, there showed no difference in the amount of collagen positively 
stained (Figure 8). Representative images of both genotypes are presented in Figure 8B. 
Note the tubular dilation present in the heterozygous mice compared to the wildtype 
mice.  
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Figure 8. Collagen deposition after adenine diet. (A). 20x magnification representative 
images are presented for reference. (B). 6 images from each mouse (n=5) were quantified 
using ImageJ software to detect the amount of red, positively stained collagen. 
 
There was no significant difference between the amount of blue collagen between 
TMIGD1 +/- and wild type mice (Figure 9). There was a noticeable variation in the 
values obtained of the wild type mice. When comparing the images presented in Figure 
7B, the red appears to be a darker color in the wild type mice than the heterozygous mice. 
To ensure proper comparison, all slides were sectioned at 4 microns. Additionally, this 
was consistent among all mice of this group.  
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Figure 9. Trichrome analysis of treated and untreated tissue. (A and D) 
Representative images were captured at 20x magnification for quantification and 
presented as a reference. (B). Images were quantified using ImageJ and averaged based 
on the amount of positive stain for collagen for untreated kidneys (p= 0.2363 not 
significant). (C) Treated kidneys presented collagen showed no significant difference 
between the wild type and heterozygous mice (p = 0.1831, not significant).  
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Table 1. Compiled statistical analyses. All statistical values are compiled for review. 
Serum samples were used for the detection of BUN and Creatinine. Weight 
measurements were obtained periodically throughout the 0.2% Adenine experiment. 
Special staining for each animal was evaluated on 6 images for the % Area quantification 
of positive staining. The ‘&’ symbol indicates a 2-way ANOVA with Bonferroni 














Figure 10. TMIGD1 Expression in Untreated Kidney of Transgenic Murine Model 
Stain for TMIGD1 in the TMIGD1+/+ (WT), TMIGD1 +/-, and TMIGD1 -/- untreated 
kidney. Immunofluorescent antibodies [1:500] targeting TMIGD1 were used to 
demonstrate the efficacy of CRISPR/Cas9 mutation. 
 
Villin expression decreased from the wild type mice kidneys to the 0.2% adenine 
exposed kidneys. More notably, the TMIGD1 heterozygous mice treated with 0.2% 
adenine experienced a significant decrease in the expression of villin supported by the 






Figure 11. TMIGD1 and Villin Expression in adenine model. TMIGD1 +/+ exposed 
to 0.25% and 0.2% adenine diet were compared to 0.2% adenine treated TMIGD1 +/- 










Figure 12. Western Blot Analysis of 0.2% Adenine Treated Renal Tissue. TMIGD1 
+/+ (WT) and TMIGD1+/- Treated with 0.2% Adenine. 50 µg lysate was added to a 10% 
SDS gel and were probed for Villin and TMGID1. Ponceau Red stain was used to 
demonstrate equal loading.     
 
TMIGD1 expression decreased in the treated mice in the CRISPR/Cas9 mice. To 
investigate the role of TMIGD1 and cell-cell interaction, we chose to co-stain via 
immunofluorescence of kidney tissue with Villin and TMIGD1. Villin is a representative 
protein for brush border found on proximal tubules. As shown in Figure 11, TMIGD1 +/- 
the brush border is not complete and TMIGD1 is apically expressed with incomplete 





Figure 13. Villin Expression 0.25% Adenine Diet. Imaged above 0.25% adenine 
treated TMIGD1 +/+ (left) and TMIGD1+/- (right) kidneys exposed for 14 days.  
 
In an effort to better understand brush border damage of renal proximal tubules, 
villin expression was investigated. To confirm findings in the western and 
immunofluorescent images captured in Figure 12, tissue from a previous experiment 
where TMIGD1 +/+ and TMIGD1 +/- mice were exposed to 0.25% adenine for 14 days 
were analyzed to determine consistency of villin expression and loss. Though the 
duration of exposure was different, both groups of mice had reached end stage renal 
disease, similar to those treated with 0.2% adenine for 32 days. On the left demonstrates a 
characteristic group of renal proximal tubules after exposure and the right are an example 
of TMIGD1 heterozygote. Exposure to 0.25% Adenine Chow for 14 days continued to 







Previous reports of the transcription regulation via C/EBP- b for TMIGD1 in 
C57BL6 mice (TMIGD1+/+) were supported by the relative expression captured in figure 
2 and 3. Initial analysis of animal models produced consistent observation of a decrease 
in protein expression of TMIGD1 and the location change of C/EBP-b from the nucleus 
to the cytoplasm when chronic kidney disease is onset (Figure 2). C/EBP-b nuclear 
location is influenced my uremic solutes present in kidneys and changes the function of 
the ubiquitous protein (Duranton et al., 2012). At higher magnification, the location of 
TMIGD1 in the wildtype renal proximal tubules, reveal apical expression that is 
consistent with the extracellular location and cell-cell interaction similar to the IGPR-1 
family proteins (Figure 3).   
 To further investigate the role of the transcriptional regulator C/EBP-b and its 
translocation, HK2 cells were used to determine the response to uremic solutes. Indoxyl 
sulfate is known to be increased in patients who undergo hemodialysis (Duranton et al., 
2012; Leong and Sirich, 2016; and Moshe et al., 2015). Additionally, indoxyl sulfate 
induces oxidative stress of renal proximal tubules due to the imbalance of pro- and 
antioxidant mechanisms in endothelial cells by catalyzing ROS production that leads to 
NAD(P)H oxidase activity, and decreases glutathione levels (Duo et al., 2007).  In vitro 
analysis from HK2 cells exposed to Indoxyl sulfate demonstrate the change in location of 
nuclear C/EBP-beta (Figure 4). Indoxyl acetate is produced as a byproduct of indoxyl 
sulfate production in the liver and induces the production of pro-inflammatory activity 
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that could lead to renal epithelial stress (Moshe et al., 2015). Kynurenine is a byproduct 
of tryptophan degradation in the liver and is also secreted through the urine. Together, 
these proteins induce epithelial stress and are pro-thrombotic for which thrombus 
formation can produce occlusion of blood vessels and cause oxidative stress (Tankiewicz 
et al., 2013; Moshe et al., 2015). The exposure to each endogenously produced solute, in 
pathophysiological conditions, caused a localization change of the nuclear C/EBP-b to 
the cytoplasm (Figure 4). Each solute also increases risk for tubulointerstitial fibrosis, 
mediated by organic anionic transporters (OAT) that excrete the uremic solutes from the 
tubular epithelial cells (Moshe et al., 2015). In cell culture, the limited amount of OAT 
produces similar conditions for that of patients with renal injury (Leong and Sirich, 
2016). Based on these results, we hypothesize TMIGD1 expression under stress from 
uremic solutes, compounded with the primarily cytoplasmic CEBP- b would reduce in a 
model for renal injury (Figure 2 and 4). 
The adenine diet was selected to induce end stage renal disease due to the 
characteristic tubulointerstitial fibrosis and oxidative stress. Wild-type and TMIGD1 
heterozygous mice were administered 0.2% Adenine for 32 days to represent chronic 
exposure and renal response. Plasma was collected at two weeks after exposure and at 
termination. BUN values indicate severe renal injury after two weeks in both groups 
(Figure 5A and 5B). Interestingly, at termination, the wild-type (TMIGD1 +/+) mice 
reported a decrease in BUN demonstrating repair whereas the TMIGD1 heterozygous 
mice remained severely injured (Figure 5B). Data reported suggests statistical 
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significance using a Students T test of BUN values after 32 days of exposure to 0.2% 
adenine diet.  
In an effort to monitor overall health of the different genotypes and the known 
weight loss due to diet, the average change in weight is reported and is not produce 
statistical significance when compared (Figure 5C). The plasma values of creatinine were 
measured from mice collected at termination (Figure 5D). Due to limited sample size and 
the amount of plasma collected, the values reported do not produce statistically 
significant results. With a larger sample size and an experiment powered to analyze this 
value, a better assessment may be deduced. Based on initial report in Figure 5D, I believe 
there may be a difference between groups, as there was an outlier among the wild type 
group that reported double the value of creatinine than others in the sampled population.  
As renal injury is the primary focus of this study, at termination the total kidney 
weight was compared between populations and the functional renal mass was reported. 
The heterozygous mice had a significantly larger renal mass than the wild-type mice as 
well as had less variability (Figure 5E). At first glance, it appears that the TMIGD1 
heterozygous mice have more renal mass than the wild-type mice. After observing the 
Serum BUN and Creatinine values, it becomes more apparent that the renal health of the 
TMIGD1 heterozygous mice is experiencing more damage.  Renal injury can cause 
hypertrophy and produce a false positive for renal health when only comparing weight 
(Chevalier, 2016). 
 In order to support the hypothesis that the TMIGD1 heterozygous mice are under 
greater stress, the Periodic Acid Schiff (PAS) stain was performed to measure the amount 
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of mucin and glycogen present in the kidney. Images were quantified using ImageJ and 
produced significantly different values of the 0.2% adenine treated populations (Figure 
6A). Images captured at 40x magnification show representative of each genotype (figure 
6B). Renal Pathologists then graded each image used for quantification and were 
averaged to demonstrate the relative tubular atrophy and interstitial injury (Figure 6C).   
 In order to further evaluate the disease model, treatment naïve mice were stained 
for PAS and compared. Measurements indicate that there is a stepwise correlation with 
the allele loss of the TMIGD1 (Figure 6D and 6E). Pathologist scoring indicated a 
difference between treated populations in relationship to the tubule dilation (Figure 6F). 
Data suggests a haploinsufficiency associated with TMIGD1 and positive PAS stain for 
glycogen and mucin deposition. When the values of the treatment naïve and adenine 
exposed mice of the same genotype were compared, the TMIGD1+/+ and TMIGD1+/- 
mice showed a nonsignificant increase of glycogen. In an attempt to confirm the 
progression to CKD, the glycogen deposition and the quantification of interstitial fibrosis, 
and ECM accumulation could provide more insight on renal health (Farris and Alpers, 
2014).  
During the analysis of the stain intensity, tubule dilation in both mice was 
apparent, signifying acute kidney injury. Using the images quantified for the PAS stain, 
the number of proximal tubules dilated in each field were counted as well as the number 
of proximal tubules that presented with necrotic debris in the lumen (Figure 9). 
Interestingly, we found a statistical difference in the number of dilated tubules between 
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treated mice. This information would indicate that in the 20x field, there was less tissue 
present in the TMIGD1 +/- group than the TMIGD1 +/+ group.  
 Due to PAS stain detection of glycogen and mucin, and the known response of 
tubulointerstitial fibrosis in the adenine model, a picrosirius red and trichrome stain was 
used to identify the degree of fibrosis and to determine which type of collagen. When the 
TMIGD1 +/+ mice were compared to TMIGD1 +/-, there was no statistical difference 
between the populations (Figure 8). The representative images in Figure 8B show a large 
portion of the tubular dilation compared to the wild type mice, consistent with the serial 
sections used for the PAS stain. It is my belief that though the amount of collagen stained 
by both trichrome and picrosirius red stain are not producing different results between 
populations, the values need to be normalized to the amount of tissue relative to the open 
space caused by tubular dilation. Trichrome stain was also used to quantify the amount of 
fibrosis by the collagen deposition in both untreated and 0.2% adenine treated mice 
(Figure 9). Neither group showed statistical significance when compared given the small 
sample size.  
TMIGD1 expression decreased in the treatment naïve mice proportionally in the 
CRISPR/Cas9 mice (Figure 10). To investigate the role of TMIGD1 and cell-cell 
interaction, we chose to co-stain via immunofluorescence of kidney tissue with Villin and 
TMIGD1 (Figure 11). Villin is a representative protein for brush border found on 
proximal tubules. The brush border in TMIGD1 +/- mice is thinner than that of the wild 
type treated mice and is apically expressed with incomplete endothelial expression 
(Figure 11 and 13). Due to villin’s normal location restricted to epithelial cells with a 
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brush border, which happen to be renal proximal tubules and intestines (Gröne et al., 
1986) we suspect there is a homology associated with TMIGD1 protein and villin 
expression.  
When exposed to the adenine diet the TMIGD1+/+ mice presented with less 
TMIGD1 expression than the untreated mice but more than the transgenic TMIGD1 +/- 
mice treated, similar to that of the transgenic mouse untreated (Figure 10). The untreated 
kidneys villin was very prominent and used as a positive control when comparing the 
renal injury models (Figure 10). Imaged Villin and TMIGD1 decreased in the 
heterozygous mice when compared to wild type in short term progression of ESRD with 
exposure to 0.25% adenine for 2 weeks and then chronic exposure of 0.2% adenine for 32 
days (Figure 11 and 12). Western blot analysis supported our histological findings, that 
from the treated tissue from the transgenic TMIGD1 +/-, there is little to no villin 
expression when compared to the TMIGD1 +/+ untreated and then treated with adenine 
diet.  
In conclusion, we believe data presented throughout this thesis supports the 
hypothesis that the loss of TMIGD1 in untreated transgenic mice produces a statistically 
significant stepwise phenotype for glycogen and mucin deposition. When exposed to the 
adenine diet, TMIGD1 +/+ and TMIGD1 +/- mice presented similar onset of disease but 
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